LifeTech ScientificLFTSF 96 PE Ratio (TTM) is 46.70 as of Jul. 03, 2026, which is 7% above its 10-year median of 43.68. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.33. The stock has 4 warning signs investors should review. Among 435 Medical Devices & Instruments companies, LifeTech Scientific ranks worse than 68.28% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-03), LifeTech Scientific's share price is
$0.2335.
LifeTech Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01. Therefore, LifeTech Scientific's PE Ratio (TTM) for today is 46.70.
The historical rank and industry rank for LifeTech Scientific's PE Ratio (TTM) or its related term are showing as below:
LFTSF'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 20.31 Med: 43.68 Max: 1980
Current: 40
During the past 13 years, the highest PE Ratio (TTM) of LifeTech Scientific was 1980.00. The lowest was 20.31. And the median was 43.68.
LFTSF's PE Ratio (TTM) is ranked worse than 68.28% of 435
companies
in the Medical Devices & Instruments industry
Industry Median: 26.74
vs LFTSF: 40.00
During the past 12 months, LifeTech Scientific's average EPS without NRIGrowth Rate was -34.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -24.80% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 12.30% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 13.20% per year.
During the past 13 years, LifeTech Scientific's highest 3-Year average EPS without NRI Growth Rate was 65.60% per year. The lowest was -33.90% per year. And the median was 15.70% per year.
LifeTech Scientific's EPS (Basic) for the
six
months ended in Dec. 2025 was $0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
LifeTech Scientific (OTCPK:LFTSF) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
LifeTech Scientific PE Ratio (TTM) Related Terms
LifeTech Scientific PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LifeTech Scientific's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
LifeTech Scientific's Share Price of today is $0.2335.
For company reported semi-annually, LifeTech Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
LifeTech Scientific (LFTSF) has a PE Ratio (TTM) of 46.70 as of Jul. 03, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on LifeTech Scientific and its competitors. This is near median its historical median of 43.68. Over the past decade, LifeTech Scientific's PE Ratio (TTM) has ranged from 20.31 to 1,980.00. According to the industry distribution chart, LifeTech Scientific ranks #297 out of 435 companies in the Medical Devices & Instruments industry, placing it in the top 68.3%.
Is LifeTech Scientific's PE Ratio (TTM) too high?
LifeTech Scientific's current PE Ratio (TTM) of 46.70 is near median its 10-year median of 43.68. Over the past 10 years, this metric has ranged from a low of 20.31 to a high of 1,980.00. The Medical Devices & Instruments industry median PE Ratio (TTM) is 26.74. LifeTech Scientific's value of 46.70 is 74.6% above this industry median. Based on the distribution chart, LifeTech Scientific ranks #297 out of 435 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's PE Ratio (TTM) compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #297 out of 435 companies for PE Ratio (TTM). This places LifeTech Scientific in the lower half of its industry. The industry median PE Ratio (TTM) is 26.74. LifeTech Scientific's value of 46.70 is 74.6% above this benchmark. Historically, LifeTech Scientific's own PE Ratio (TTM) has ranged from 20.31 to 1,980.00 over the past decade. While the company's 10-year median is 43.68 vs. the industry median of 26.74, LifeTech Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 26.74, based on 435 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current PE Ratio (TTM) of 46.70 is 74.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 26.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current PE Ratio (TTM) is 46.70, which is near median its own 10-year median of 43.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current PE Ratio (TTM) of 46.70. The stock's GF Value™ is $0.33, compared to a current price of $0.23 — trading 29.2% below its estimated fair value. The current PE Ratio (TTM) is 46.70, which is near median its 10-year median of 43.68 and 74.6% above the Medical Devices & Instruments industry median of 26.74. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current PE Ratio (TTM) is 46.70 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 29.2% below its estimated GF Value™ of $0.33.
Key valuation signals for LFTSF:
PE Ratio (TTM): 46.70 (near median its 10-year median of 43.68)
GF Value™: $0.33 vs. price of $0.23 (29.2% below fair value)
Industry Position: 74.6% above the Medical Devices & Instruments median (#297 of 435)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
